Početna stranicaBAX • NYSE
add
Baxter International Inc
35,35 $
Poslije radnog vremena:(0,14 %)−0,050
35,30 $
Zatvoreno: 19. srp, 17:39:25 GMT -4 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
35,68 $
Dnevni raspon
35,17 $ - 35,87 $
Godišnji raspon
31,01 $ - 50,21 $
Tržišna kapitalizacija
18,01 mlr. USD
Prosječna količina
5,07 mil.
P/E omjer
6,79
Prinos dividende
3,28 %
Glavno tržište vrijednosnica
NYSE
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (USD) | ožu 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 3,59 mlr. | 2,25 % |
Operativni troškovi | 1,05 mlr. | 1,64 % |
Neto dohodak | 37,00 mil. | −15,91 % |
Neto profitabilnost | 1,03 | −17,60 % |
Zarada po dionici | 0,65 | 10,17 % |
EBITDA | 696,00 mil. | 16,00 % |
Efektivna porezna stopa | 66,38 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (USD) | ožu 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 3,03 mlr. | 80,87 % |
Ukupna imovina | 27,79 mlr. | −1,78 % |
Ukupne obveze | 19,55 mlr. | −12,51 % |
Ukupni kapital | 8,24 mlr. | — |
Dionice u optjecaju | 509,58 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 2,22 | — |
Povrat imovine | 3,22 % | — |
Povrat kapitala | 3,99 % | — |
Tok novca
Neto promjena novca
| (USD) | ožu 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 37,00 mil. | −15,91 % |
Gotovina od poslovanja | 163,00 mil. | −65,97 % |
Gotovina iz ulaganja | −166,00 mil. | 2,35 % |
Gotovina iz financiranja | −140,00 mil. | 62,37 % |
Neto promjena novca | −168,00 mil. | −273,33 % |
Slobodan tok novca | 401,25 mil. | −23,72 % |
Više
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis. Wikipedia
Glavni izvršni direktor
Osnovano
1931
Web-lokacija
Zaposlenici
60.000
